Antibiotic resistance is a global problem but there have been no new drugs produced since the 1980s. So who is to blame? The public's over-consumption or the current economic model for drug research and production? Evan Davis and guests discuss.
Seema Patel, Medical Director, Hospital Business, Pfizer, UK, Ireland and the Nordics
Lord Jim O'Neill, Chair Anti-Microbial Resistance Review (2016), Former Chief Economist, Goldman Sachs
Professor Colin Garner, Co Founder and Director, Antibiotic Research UK
Planning for uncertainty
Every business faces uncertainty. In the final programme of the series Evan Davis and guests ask what businesses should do when faced with uncertainty.
Jeremy Bentham, Head of Scenarios, Shell
Nick Allan, CEO, Control Risks
Dr Sandra Bell, Head of Resilience Consulting, Sungard Availability Services
It's hard to buy anything these days without being asked to rate or review it. Evan Davis and guests look at how have businesses such as Tripadvisor, Feefo and Checkatrade have altered the relationship between companies and consumers? Do you trust the wisdom of crowds more than an expert's view?
Matt West, Chief Executive of Feefo
Rob Paterson, Chief Executive of Best Western Hotels GB
Caroline Wiertz, Professor of Marketing and Associate Dean for Entrepreneurship at the Cass Business School in LOndon
For many graduates an internship has become the default route to full-time, paid employment. But getting a good placement is competitive and in some cases poorly paid or unpaid. What does this mean for social mobility and diversity in the workplace? Evan Davis and guests discuss the pros and cons of internships.
Sarah Churchman, UK Head of Inclusion, Diversity and Wellbeing, PwC
Amalia Illgner , Freelance journalist and a former intern
Oliver Sidwell, Co-founder, Rate My Placement
The personalisation revolution
Technological advances have made it easier for businesses to offer us more personalised goods and services, from customised cars to clothes that fit better and pioneering cell and gene therapies to target serious illnesses. How far can this personalisation revolution go?
Darrin Disley, Chief Executive of cell therapy company, Mogrify
Georgina Silvester, Chief Operating Officer (designate), Handelsbanken UK
Karl Howkins, Managing Director, Citroen UK
Kate Ancketill, Chief Executive of GDR Creative Intelligence